Personal Injury Law

Caraco Digoxin Recall Issued March 31, 2009 Is Due To Pill-Size Problems

By Tom Lamb

Digitek Brand Of Generic Digoxin Tablets Had Been Recalled In April 2008 For Same Reason

(Posted by Tom Lamb at DrugInjuryWatch.com)

On March 31, 2009 the FDA announced another generic digoxin pill recall by posting this company press release on the agency's web site: "Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size Variability".

This March 31 press release from Caraco, a generic pharmaceutical company, states that:

[A]ll tablets of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September, 2011, are being voluntarily recalled to the consumer level. The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin."

Almost a year ago, in late April 2008, all digoxin pills manufactured by Actavis Totowa -- marketed under the Digitek brand name -- were recalled due to this so-called "double-dose" manufacturing problem.  Those Digitek pills were distributed by Mylan Pharmaceuticals under the Bertek and UDL labels.

The Digitek recall has resulted in personal injury and wrongful death lawsuits being filed on behalf of patients who used Digitek digoxin tablets.

It is too early to tell whether there will be any product liability litigation involving the possible "double-dose" digoxin pills that are now being by Caraco Pharmaceutical.

Full post as published by Drug Injury Watch on March 31, 2009 (boomark / email).